Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Gallbladder Neoplasms × Neoadjuvant Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 11 Rectal Neoplasms 9 Colorectal Neoplasms 7 Stomach Neoplasms 6 Esophageal Squamous Cell Carcinoma 6 Esophageal Neoplasms 6 Neoplasm Metastasis 4 Nasopharyngeal Carcinoma 4 Carcinoma, Non-Small-Cell Lung 4 Adenocarcinoma Of Esophagus 4 Uterine Cervical Neoplasms 3 Pancreatic Neoplasms 3 Neuroblastoma 3 Lung Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Prostatic Neoplasms 2 Peritoneal Neoplasms 2 Multiple Myeloma 2 Melanoma 2 Inflammatory Breast Neoplasms 2 Head and Neck Neoplasms 2 Fallopian Tube Neoplasms 2 Colonic Neoplasms 2 Central Nervous System Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Adenocarcinoma 2 Wilms Tumor 1 Uveal Melanoma 1 Stage III and IV Ovarian Cancer 1 Sarcoma 1

Interventions

Gemcitabine 12 Cisplatin 9 Capecitabine 7 pembrolizumab 3 Oxaliplatin 3 Chemotherapy, Adjuvant 3 durvalumab 2 Watchful Waiting 2 Leucovorin 2 zanidatamab 1 Tegafur 1 Somatostatin 1 S 1 (combination) 1 Phototherapy 1 Photochemotherapy 1 Ondansetron 1 Neoadjuvant Therapy 1 Laser Therapy 1 Irinotecan 1 Folfox protocol 1 Fluorouracil 1 Fentanyl 1 Escitalopram 1 Epirubicin 1 Dihematoporphyrin Ether 1 Dexamethasone 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06712420 2025-04-16

NEOGB

Rajiv Gandhi Cancer Institute & Research Center, India

Phase 3 Recruiting

Gastrointestinal

Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡